315 related articles for article (PubMed ID: 36936929)
1. Identification of lactylation related model to predict prognostic, tumor infiltrating immunocytes and response of immunotherapy in gastric cancer.
Yang H; Zou X; Yang S; Zhang A; Li N; Ma Z
Front Immunol; 2023; 14():1149989. PubMed ID: 36936929
[TBL] [Abstract][Full Text] [Related]
2. A multi-dimensional approach to unravel the intricacies of lactylation related signature for prognostic and therapeutic insight in colorectal cancer.
Huang H; Chen K; Zhu Y; Hu Z; Wang Y; Chen J; Li Y; Li D; Wei P
J Transl Med; 2024 Feb; 22(1):211. PubMed ID: 38419085
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive analysis of tumor immune microenvironment and prognosis of m6A-related lncRNAs in gastric cancer.
Wang Y; Zhu GQ; Tian D; Zhou CW; Li N; Feng Y; Zeng MS
BMC Cancer; 2022 Mar; 22(1):316. PubMed ID: 35331183
[TBL] [Abstract][Full Text] [Related]
4. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
[TBL] [Abstract][Full Text] [Related]
5. A new risk model based on a 11-m
Lei L; Li N; Yuan P; Liu D
BMC Cancer; 2022 Apr; 22(1):365. PubMed ID: 35382776
[TBL] [Abstract][Full Text] [Related]
6. Development of a Comprehensive Gene Signature Linking Hypoxia, Glycolysis, Lactylation, and Metabolomic Insights in Gastric Cancer through the Integration of Bulk and Single-Cell RNA-Seq Data.
Zhang X; Li Y; Chen Y
Biomedicines; 2023 Nov; 11(11):. PubMed ID: 38001949
[TBL] [Abstract][Full Text] [Related]
7. NF-
Chen Q; Du X; Hu S; Huang Q
Biomed Res Int; 2022; 2022():5092505. PubMed ID: 35036435
[TBL] [Abstract][Full Text] [Related]
8. The cancer-associated fibroblast-related signature predicts prognosis and indicates immune microenvironment infiltration in gastric cancer.
Mak TK; Li X; Huang H; Wu K; Huang Z; He Y; Zhang C
Front Immunol; 2022; 13():951214. PubMed ID: 35967313
[TBL] [Abstract][Full Text] [Related]
9. Lactylation-Related Gene Signature Effectively Predicts Prognosis and Treatment Responsiveness in Hepatocellular Carcinoma.
Cheng Z; Huang H; Li M; Liang X; Tan Y; Chen Y
Pharmaceuticals (Basel); 2023 Apr; 16(5):. PubMed ID: 37242427
[TBL] [Abstract][Full Text] [Related]
10. AFF3 is a novel prognostic biomarker and a potential target for immunotherapy in gastric cancer.
Zeng Y; Zhang X; Li F; Wang Y; Wei M
J Clin Lab Anal; 2022 Jun; 36(6):e24437. PubMed ID: 35478418
[TBL] [Abstract][Full Text] [Related]
11. Identification and validation of the prognostic value of cyclic GMP-AMP synthase-stimulator of interferon (cGAS-STING) related genes in gastric cancer.
Yang KS; Xu CQ; Lv J
Bioengineered; 2021 Dec; 12(1):1238-1250. PubMed ID: 33843442
[TBL] [Abstract][Full Text] [Related]
12. High expression of TMEM200A is associated with a poor prognosis and immune infiltration in gastric cancer.
Deng H; Li T; Wei F; Han W; Xu X; Zhang Y
Pathol Oncol Res; 2023; 29():1610893. PubMed ID: 36741965
[No Abstract] [Full Text] [Related]
13. Development and validation of a necroptosis-related gene prognostic score to predict prognosis and efficiency of immunotherapy in gastric cancer.
Xia Y; Zhang R; Wang M; Li J; Dong J; He K; Guo T; Ju X; Ru J; Zhang S; Sun Y
Front Immunol; 2022; 13():977338. PubMed ID: 36159818
[TBL] [Abstract][Full Text] [Related]
14. A nomogram model based on the number of examined lymph nodes-related signature to predict prognosis and guide clinical therapy in gastric cancer.
Li H; Lin D; Yu Z; Li H; Zhao S; Hainisayimu T; Liu L; Wang K
Front Immunol; 2022; 13():947802. PubMed ID: 36405735
[TBL] [Abstract][Full Text] [Related]
15. Weighted Gene Co-expression Network Analysis Identifies a Cancer-Associated Fibroblast Signature for Predicting Prognosis and Therapeutic Responses in Gastric Cancer.
Zheng H; Liu H; Li H; Dou W; Wang X
Front Mol Biosci; 2021; 8():744677. PubMed ID: 34692770
[No Abstract] [Full Text] [Related]
16. Lactate-Lactylation Hands between Metabolic Reprogramming and Immunosuppression.
Chen L; Huang L; Gu Y; Cang W; Sun P; Xiang Y
Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233246
[TBL] [Abstract][Full Text] [Related]
17. Identification of TAP1 as a T-cell related therapeutic target in gastric cancer by mediating oxalipliatin-related synergistic enhancement of immunotherapy.
Zhao Y; Liu Z; Deng K; Qu H; Zhang Q; Zhou P; Yang M; Yang X; Wang H; Li R; Xia J
Int Immunopharmacol; 2024 May; 132():111998. PubMed ID: 38593510
[TBL] [Abstract][Full Text] [Related]
18. Lactylation-related gene signature for prognostic prediction and immune infiltration analysis in breast cancer.
Jiao Y; Ji F; Hou L; Lv Y; Zhang J
Heliyon; 2024 Feb; 10(3):e24777. PubMed ID: 38318076
[TBL] [Abstract][Full Text] [Related]
19. Identification of lactylation gene CALML5 and its correlated lncRNAs in cutaneous melanoma by machine learning.
Feng H; Chen W; Zhang C
Medicine (Baltimore); 2023 Nov; 102(47):e35999. PubMed ID: 38013352
[TBL] [Abstract][Full Text] [Related]
20. Combining single-cell sequencing data to construct a prognostic signature to predict survival, immune microenvironment, and immunotherapy response in gastric cancer patients.
Hu B; Meng Y; Qu C; Wang BY; Xiu DR
Front Immunol; 2022; 13():1018413. PubMed ID: 36300104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]